About AmacaThera
AmacaThera is a company based in Toronto (Canada) founded in 2015. AmacaThera has raised $14.22 million across 3 funding rounds from investors including BDC, Viva BioInnovator and Lumira Ventures. AmacaThera operates in a competitive market with competitors including Augmenix, Regentis Biomaterials, LifeSprout, Biosyntech and ECM Therapeutics, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.22 M (USD)
in 3 rounds
-
Latest Funding Round
$8.16 M (USD), Series A
Feb 22, 2021
-
Investors
BDC
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of AmacaThera
Unlock access to complete
Unlock access to complete
Funding Insights of AmacaThera
AmacaThera has successfully raised a total of $14.22M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8.16 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $8.2M
-
First Round
First Round
(11 Jan 2019)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series A - AmacaThera | Valuation | Lumira Ventures | |
| Oct, 2019 | Amount | Seed - AmacaThera | Valuation | Sprout BioVentures , Viva BioInnovator | |
| Jan, 2019 | Amount | Seed - AmacaThera | Valuation | Sprout BioVentures , Viva BioInnovator |
Investors in AmacaThera
AmacaThera has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include BDC, Viva BioInnovator and Lumira Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Founded Year | Domain | Location | |
|
Biotechnology startups are incubated and funded by Viva BioInnovator.
|
Founded Year | Domain | Location | |
|
Online lottery results are provided for Hongkong players daily.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AmacaThera
Financial Statements - AmacaThera
Amacathera Comparisons
Competitors of AmacaThera
AmacaThera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmenix, Regentis Biomaterials, LifeSprout, Biosyntech and ECM Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hydrogel spacers are provided for prostate cancer radiation therapy.
|
|
| domain | founded_year | HQ Location |
Regentis Biomaterials is focused on tissue repair hydrogel technology.
|
|
| domain | founded_year | HQ Location |
Synthetic soft tissue substitutes for cosmetics and reconstructive surgery
|
|
| domain | founded_year | HQ Location |
Biotherapeutic thermogels are developed for tissue repair applications.
|
|
| domain | founded_year | HQ Location |
Diagnostic and therapeutic products from extracellular matrix are developed.
|
Latest news on Amacathera
Frequently Asked Questions about AmacaThera
AmacaThera was founded in 2015 and raised its 1st funding round 4 years after it was founded.
AmacaThera is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
AmacaThera is a funded company, having raised a total of $14.22M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.46M, raised on Jan 11, 2019.
AmacaThera was founded in 2015 in Toronto, Canada, within the biotechnology sector. An injectable hydrogel platform is developed by the company for diverse medical uses, including the delivery of pharmacological agents to address multiple disease areas. Operations focus on therapeutic innovations, with a combination product created for managing post-operative pain. The platform supports applications in healthcare delivery across various indications.
AmacaThera's top competitors include Augmenix, LifeSprout and Regentis Biomaterials.
AmacaThera has 10 investors. Key investors include BDC, Viva BioInnovator, Lumira Ventures, HK Pools, and Inveready.